VEGFA and neoplasm: Importantly, intratumorally and i.v. administered VEGF-specific shRNA-expressing oAd-PPCBA nanocomplex induced a 3-fold more potent antitumor effect than naked Ad in human xenograft tumor models with a lower level of systemic toxicity [89].